Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity
Launched by 3-C INSTITUTE FOR SOCIAL DEVELOPMENT · Dec 10, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new digital program called FBT 2.0, designed to help children and their families tackle childhood obesity. The program aims to provide a comprehensive online platform that includes personalized activities for children, training and support for those helping with the intervention, and tools to keep families engaged and track progress. It’s all about making the journey to a healthier lifestyle easier and more interactive for both kids and their caregivers.
To participate in this trial, children need to be between 6 and 18 years old and have a body mass index (BMI) that is higher than what is considered healthy for their age and gender. Additionally, at least one caregiver, who must be an adult living with the child most of the time, needs to be involved. Participants can expect to access engaging online materials that are tailored to their needs, helping them learn about healthier habits in a fun way. This trial is not yet recruiting participants, so keep an eye out for updates if you think this could be a good fit for your family!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • must be youth between the ages of 6 and 18
- • must have a body mass index (BMI) percentile greater than or equal to the 95th BMI percentile for age and sex
- • must have one caregiver participate, who is at least 18 years of age and lives with the child at least 50% of the time.
- Exclusion Criteria:
- • co-morbid disorders that contraindicate weight loss (e.g., eating disorder).
About 3 C Institute For Social Development
The 3-C Institute for Social Development is a pioneering organization dedicated to advancing research and intervention strategies that enhance social development and community well-being. With a focus on evidence-based practices, the institute conducts innovative clinical trials aimed at addressing critical social issues and improving health outcomes. Leveraging a multidisciplinary approach, the 3-C Institute collaborates with academic, governmental, and non-profit partners to translate research findings into actionable solutions. Committed to ethical standards and community engagement, the institute strives to foster sustainable social change through rigorous evaluation and impactful program implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Melissa DeRosier, PhD
Principal Investigator
3C Institute
Denise Wilfley, PhD
Principal Investigator
Washington University School of Medicine
Leonard Epstein, PhD
Principal Investigator
University at Buffalo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported